Objective To investigate the association between assisted reproductive technology and severe postpartum haemorrhage.
Introduction
At present, more than 3% of children are conceived by ART in several countries throughout Europe. The prevalence of infertility is estimated to be around 9% worldwide. 1 The fact that fertility declines with age, as well as the trend toward later child-bearing, with more women over 30 years of age giving birth, [1] [2] [3] may contribute to an increased number of ART cycles worldwide. 4 Severe postpartum haemorrhage (PPH) contributes substantially to maternal morbidity in high-income countries, causing >50% of all events of severe maternal morbidity. 5 Studies have shown an increasing trend in PPH, but the causes for this increase are still uncertain. 6, 7 There is a paucity of information in the literature regarding the association between severe PPH and ART. Only a few previous studies have reported on the association, mainly from retrospective infertility cohorts. [8] [9] [10] [11] Singleton ART pregnancies are usually managed as low-risk deliveries and details of the ART treatment are sometimes kept confidential. Our ability to take appropriate preventive measures when it comes to severe PPH relies on the awareness of an increased risk of PPH, illustrating the need for continued research into risk factors for PPH.
Our aim was to investigate the association between ART and severe PPH, and to clarify whether other potential risk factors for severe PPH modified the association.
Methods
The case-control design was considered adequate because severe PPH is a rare event happening in about 1% of all deliveries. 12, 13 The source population was all women admitted for labour at gestational week ≥23 at two obstetrical departments at Oslo University Hospital (Ullevaal and Rikshospitalet) and at Drammen Hospital in Buskerud municipality, during the period from 1 January 2008 to 31 December 2011. In total, we identified 1064 cases of severe PPH (defined as blood loss ≥1500 ml or the need for blood transfusion) through birth suite protocols and hospital databases. Controls were a random sample of all deliveries without severe PPH from the same source population and period as the cases derived, comprising a total of 2059 deliveries ( Figure 1 ). The random sample was generated in STATA version 13.0 (StataCorp LP, College Station, TX, USA), with a sampling fraction at Rikshospitalet, Ullevaal, and Drammen Hospital of 4.8, 5.2, and 4.7%, respectively. If a woman appeared with more than one delivery in our database, the second and subsequent pregnancies were excluded to avoid correlations.
A de facto power analysis indicated that given the available sample size of 1064 cases of severe PPH and 2059 control subjects, we would be able to detect a 1.75 times increased odds of being conceived by ART in cases compared to controls (OR = 1.75), considering an ART frequency of 3% in Norway, 13 two controls per case, and the conventional type I error of 5% and power of 80%.
ART defines procedures that involve in vitro handling of both human oocytes and sperm or embryos with the purpose of obtaining a pregnancy.
14 These techniques include both conventional in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) before one or more embryos are transferred to the uterine cavity. We did not have information on whether fresh or frozen transfer was applied in the actual pregnancy. Oocyte donations are illegal in Norway and were not considered because we lacked reliable information. Further, treatments with intrauterine inseminations were not included in the study.
We considered information on major risk factors for severe PPH and selected potential confounders or effect modifiers on the association between ART and severe PPH. Selected pre-existing risk factors and risk factors from the current pregnancy were previous severe PPH, maternal age, body mass index (BMI) at start of pregnancy, parity, multiple pregnancy (twins or higher order), uterine myomas, anaemia (haemoglobin <9 g/dl) at start of pregnancy, gestational diabetes mellitus, severe preeclampsia/HELLP (haemolysis, elevated liver enzymes and low platelet count) syndrome, placenta praevia, and use of anticoagulant medication (low-molecular-weight heparin). Factors during delivery were induction of labour, augmentation of labour with oxytocin, epidural analgesia, fever (>38°C) during labour, mode of delivery, and infant birthweight. The continuous variables BMI, infant birthweight and maternal age were also dichotomised: BMI >30 kg/m 2 according to the definition of obesity, birthweight >4500 g according to the definition of macrosomia, and maternal age >40 years.
We collected and registered patient data from several information sources; medical records, maternity databases (Obstetrix by Siemens and Partus by Clinsoft) and birth protocols. Two experienced gynaecologists investigated the medical records and the first author entered all data into a database built in EPIDATA Version 3.1 (EpiData Association, Odense, Denmark). After registration was completed, we cleaned the database and checked outliers and categorisation errors against the information in the medical records.
We used an explanatory strategy to investigate the association between ART as the exposure, and severe PPH as the outcome. The other variables were of interest as potential confounders or effect modifiers of this association. We used the odds ratio (OR) and its 95% confidence interval (CI) to quantify the association. We performed stratification analyses on each variable separately to pinpoint effect modification (interaction) using the Breslow and Day test of homogeneity, and confounding effect was identified and controlled using the Mantel-Haenszel method. The Mantel-Haenszel OR (OR MH ) is a weighted average of the odds ratios from the two separate strata of the variable, assigning more weight to the strata with the most data. The degree of confounding was evaluated by comparing the Mantel-Haenzel adjusted OR with the crude OR, and quantified as follows:
We used the logistic regression model to control for multiple confounders and effect modification (interaction). 15 In the initial model, we included the interaction terms for the three significant effect modifiers identified in the stratified analyses; ART 9 multiple pregnancy, ART 9 oxytocin stimulation during labour, ART 9 fibroma uteri, and assessed them while adjusting for the variables with considerable confounding effect >4%; mode of delivery, first pregnancy and anticoagulant medication during pregnancy. Using a manual backward elimination procedure, we considered the balance between controlling for enough confounding factors to maintain validity versus possible loss in precision from the control of too many variables. 15 Hence, the following variables were kept in the final model: mode of delivery, anticoagulant medication during pregnancy, and interaction ART 9 multiple pregnancy. The association between ART and severe PPH was reported separately on the two levels of the effect modifier: multiple and singleton pregnancy.
The statistical analyses were performed with STATA 13.0 (StataCorp LP). The Strengthening the Reporting of Observational Studies (STROBE) in Epidemiology statement guidelines were used in reporting our case-control study. 16 
Results
The characteristics of the study population are presented in Table 1 . There were no clinically significant differences in median age, BMI, or infant birthweight between cases and controls. However, the frequency of previous severe PPH, uterine myomas, multiple pregnancies, and placenta praevia was increased in the cases compared with the controls. Cases were more often nulliparous or anaemic at the start of pregnancy and more often developed severe pre-eclampsia/HELLP syndrome during pregnancy or fever during labour. The labour was more frequently induced or augmented with oxytocin, and epidural analgesia was more frequently used in the case group. Finally, deliveries by in-labour caesarean or Ventouse/forceps were more often seen among the cases.
In the severe PPH group, 10.8% (n = 115) of the pregnancies were conceived by ART, in comparison with 4.0% (n = 82) in the control group (Table 1) . We found that the proportion of women with the combination of an ART pregnancy and multiples was considerably higher among the cases of severe PPH (4.5%) than among the women in the control group (0.3%). Furthermore, an ART pregnancy was more common in combination with first delivery (8.6 versus 2.7%), use of anticoagulant medication (1.3 versus 0.1%), operative delivery (8.3 versus 2.3%), augmentation of labour (6.0 versus 2.2%), and induction of labour (3.8 versus 1.0%) in the cases with severe PPH compared with the controls (Table 2) .
The crude effect of the association between ART and severe PPH was OR = 2.92 (95% CI 2.18-3.92, P < 0.001). We identified potential confounders and effect modifiers of any association between ART and severe PPH, and performed univariate, stratified analysis to identify effect modification (interaction) and to quantify the confounding effect of the selected variables (Table 2) . A significant confounding effect (>4%) was found for the variables mode of delivery (17%), first delivery (6%), and use of anticoagulant medication in pregnancy (6%), using the formula:
Indicating interaction, a significant Breslow-Day test of homogeneity between strata (P < 0.15) was found for three variables; multiple pregnancy, augmentation of labour with oxytocin, and uterine myoma.
Results from the final multivariable analysis after backward elimination of non-significant confounders and interactions are presented in Table 3 . Taking into consideration the exposure variable ART and its interaction with multiple pregnancy, and controlling for the confounding effect of mode of delivery and anticoagulant medication, the association between ART and PPH was strongest in multiple pregnancies (adjusted OR = 7.00; 95% CI 2.70-18.12, P < 0.001) as compared with singleton pregnancies (adjusted OR = 1.58; 95% CI 1.12-2.24, P = 0.010).
Discussion

Main findings
Our study is among the first to report an association between severe PPH and ART. In the present study, women with severe PPH were more likely to have conceived with ART than were controls without severe PPH, a fact not well known among clinicians. The association was modified in the presence of a multiple pregnancy, with women carrying twins or triplets having the strongest risk of severe PPH (adjusted OR = 7.00; 95% CI 2.70-18.12, P < 0.001).
Strengths and limitations
We performed a large case-control study looking specifically at the association between ART and severe PPH. Meticulous reading of medical journals allowed a thorough exploration of potential confounders and effect modifiers. In comparison with registry-based data, we were able to investigate maternal factors with a higher precision, such as pre-existing diseases, gestational diabetes, anticoagulant medications, delivery mode, inductions, and multiple pregnancies. The study had sufficient statistical power to test our main hypothesis. We cannot exclude selection bias, but to minimise its occurrence, cases and random controls were derived from the same source population during the same time period, and the eligibility criteria applied equally to both groups. There is a probability that some cases were misclassified. Blood loss was estimated visually and may have been underestimated. In including the need for blood transfusion, we had further data in the medical records to assess the severity of the PPH and hence believe case ascertainment to be satisfactory. We cannot exclude information bias due to misclassification of exposures. Information on risk factors was collected from the patients' medical history and imprecision in measurements, subject self-report, incorrect coding of data and interviewer bias may have occurred. However, misclassification of exposure or disease status was more likely non-differential, which would have created bias toward the null effect. 17 As regards confounding, we aimed to include all relevant risk factors, but there is always a possibility of unmeasured confounding in observational studies. We believe the internal validity of this study is acceptable. Our results cannot necessarily be generalised to a wider population because our source population was partly restricted to an urban setting, hospitals in or close to Oslo. One hospital (Drammen) had a large rural intake area, but also had the fewest deliveries. 
Interpretation
An increased risk of severe PPH (OR = 1.58) remained in singleton ART pregnancies after controlling for maternal factors and pregnancy complications, indicating that ART may be an independent risk factor for severe PPH. In a cohort study of women with a history of infertility, the authors did not observe any increased risk of PPH in pregnancies conceived without ART. 11 In a register-based study, a lower risk of PPH (>500 ml) was reported in infertile women who conceived without ART compared with infertile women who conceived with ART. 7 These results support the hypothesis that ART is an independent risk factor for PPH. However, infertile women who conceived with ART in these studies may have had a different infertility diagnosis or a more severe degree of that particular diagnosis compared with infertile women who conceived spontaneously.
ART procedures may interfere with the formation of the maternal-fetal interface in the early stages of implantation. 10, 18 Structural abnormalities resulting in larger and thicker placentae have been found in ART pregnancies. [18] [19] [20] Further, epigenetic studies have shown altered gene expression in human placentae after ART. 21 These factors may play a role in early placental separation and uterine atony, and thus severe PPH. In addition, a reduced level of human chorionic gonadotropin (hCG) in the luteal phase has been associated with an increased risk of PPH in ART pregnancies, suggesting that better management of the luteal phase support could have a protective effect against PPH through a more optimal endometrial function around the time of implantation. 8 A multiple pregnancy doubled the risk of PPH in several studies, 12, 22, 23 but ART as a potential risk factor was not included in these studies. Further, most existing studies on ART and PPH excluded multiple deliveries. 8, 10, 11 We decided to include multiple pregnancies because our method would allow us to adjust for potential confounding and effect modification of a multiple pregnancy. In our study population, the association between ART and PPH was stronger in multiple pregnancies (adjusted OR = 7.00, 95% CI 2.70-18.12, P < 0.001) compared with singleton pregnancies (adjusted OR = 1.58, 95% CI 1.12-2.24, P = 0.010). Placental abnormalities reported in ART pregnancies may be even more pronounced in multiple pregnancies than singleton pregnancies, resulting in the strong joint effect of ART and multiple pregnancy found in the current study. The number of embryos transferred in ART cycles is reported to be a major determinant of the iatrogenic increase in multiple pregnancies, 4 and we advise single embryo transfer to decrease maternal morbidity caused by severe PPH.
We found no significant confounding effect or interaction with maternal pre-existing diseases or maternal pregnancy complications (gestational diabetes, pre-eclampsia/HELLP syndrome or placenta praevia) on the association between ART and severe PPH. Other studies have found an increased prevalence of placenta praevia in ART pregnancies, 24 which could partly explain an increased risk of PPH. In our study, placenta praevia was more common in ART pregnancies with severe PPH than ART pregnancies in controls. However, placenta praevia did not have any significant confounding effect nor did it modify the association between ART and severe PPH. Nor was parity, adiposity or age found to alter the association. Mode of delivery was a significant confounder. Likewise, previous studies of risk factors for PPH have shown that caesarean deliveries and instrumental vaginal deliveries are important predictors of severe PPH. 22, 23, 25 Anticoagulant medications can, through their action, increase the risk of haemorrhage. The use of anticoagulant medication was more often reported in ART pregnancies than non-ART pregnancies in our material. Likewise, a Swedish study reported a strong excess of heparin-related drugs used early in IVF pregnancies. 26 Unfortunately, indications and details of anticoagulant use are unknown.
The cause of infertility and the ART method used (IVF with or without ICSI) were unavailable in this study. Different methods may carry different risks of severe PPH, and male and female infertility may carry different risks. Female infertility caused by an implantation disorder, e.g. autoimmune implantation dysfunction, could be associated with severe PPH. We had no information on pre-pregnancy endometriosis diagnosis. Endometriosis increased the risk of severe PPH in one study (OR = 1.28). 8 Inflammatory alterations in the pelvis and at the endometrial level can affect implantation and placental structure in endometriosis 27 and predispose for PPH.
Conclusion
Women with severe PPH were more likely to have undergone ART compared with control subjects. By adding ART to the list of risk factors for severe PPH, our results indicate that women who conceived with ART should be allocated to delivery units where adequate preventive and treatment measures are available. In addition, single embryo transfer is recommended and the increased risk of PPH should be considered when counselling infertile women/couples before treatment.
Further research into factors leading to severe PPH in infertile women seems warranted. We need more knowledge about implications of the ART procedures on the risk of severe PPH, including the effect of different protocols for hormonal treatment.
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South-Eastern Norway Regional Health Authority funded the study. They had no role in the design, collection, analysis and interpretation of data, or writing of the article, or the decision to submit the article for publication. This rise in severe postpartum haemorrhage is cause for concern; it cannot be dismissed as being an artefact of increased vigilance and closer monitoring of blood loss, as objective markers of severity such as blood transfusion, hysterectomy and other invasive procedures to control blood loss have increased concurrently. The study by Nyfløt et al., which shows an increased risk of severe postpartum haemorrhage associated with assisted reproductive technologies (ART) adds a new dimension to the ongoing discussion regarding temporal trends in severe postpartum haemorrhage. Whereas infant outcomes such as preterm birth and low birthweight have been the focus of numerous studies on ART, maternal complications have received less attention. Nyfløt et al. assessed several important determinants of severe postpartum haemorrhage including body mass index, birthweight, mode of delivery, use of anti-coagulation therapy and labour augmentation and induction. They reported a modest relationship between ART and severe postpartum haemorrhage among singleton deliveries (OR 1.58; 95% CI 1.12-2.24), and a seven-fold increased risk following delivery of multi-fetal pregnancies.
It is not clear whether the mechanism underlying the demonstrated relation between ART and severe postpartum haemorrhage is related to a maternal health condition associated with reduced fertility or some aspect of ART itself. The authors' hypothesis regarding a potential effect of ART on placentation is supported by a systematic review which reported a higher risk for placenta-mediated complications such as stillbirth (OR 2.55; 95% CI 1.78-3.64), small-for-gestational age (OR 1.6; 95% CI 1.3-2.0), pre-eclampsia (OR 1.55; 95% CI 1.23-1.95), and placenta praevia (OR 2.87; 95% CI 1.54-5.37) among singleton deliveries following in vitro fertilistion (Jackson et al. Obstet Gynecol 2004; 103;551-63). In addition, both placenta accreta and placental abruption have been associated with in vitro fertilization (IVF) and IVF/ intracytoplasmic sperm injection (ICSI) (SOGC. J Obstet Gynaecol Can 2014;36;64-83). The combined and synergistic effect of placental problems due to multi-fetal pregnancy and ART potentially explain the large increased risk of severe postpartum haemorrhage among multiple pregnancies. However, it is not clear whether the multi-fetal pregnancies without ART in the Nyfløt et al. study were spontaneously conceived (or received other non-IVF methods), and clarifying the role of different technologies in the aetiology of severe postpartum haemorrhage is important.
Given the increased risk of severe postpartum haemorrhage associated with ART demonstrated in this study, as well as the increased risk of placenta praevia and placenta accreta reported in previous studies, clinicians should consider ART, specifically in pregnancies conceived by IVF or IVF/ICSI, a risk factor for severe postpartum haemorrhage. This is especially important in cases of multi-fetal pregnancy following ART where the risks of severe haemorrhage are substantially higher. On the other hand, the contribution of ART to the temporal increase in severe postpartum haemorrhage in high income countries requires further study.
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